Showing results (131-140 of 158) with videos related to
Sort By:
Pageof 16
Journal of Clinical Pharmacy and Therapeutics|September 28, 2016
Curing the historically incurable: treatment success with ledipasvir/sofosbuvir for chronic hepatitis C virus in a heavily treatment-experienced individualS W Johnson, M M Davis, L M Stever, et al.Cancer Chemotherapy and Pharmacology|January 1, 1996
Analysis of HMG protein binding to DNA modified with the anticancer drug cisplatinJ E Cryer, S W Johnson, B N Engelsberg, et al.Science (New York, N.Y.)|August 28, 1970
Apollo 12 lunar module impact: laboratory simulation and possible downrange ballistic effectsH F Swift, T R McGetchin, D D Preonas, et al.Experimental Cell Research|July 10, 1996
Cross-resistance, cisplatin accumulation, and platinum-DNA adduct formation and removal in cisplatin-sensitive and -resistant human hepatoma cell linesS W Johnson, D Shen, I Pastan, et al.Hematology/Oncology Clinics of North America|August 1, 1992
Growth regulation of ovarian cancerA K Godwin, R P Perez, S W Johnson, et al.Life Sciences|June 24, 1985
Norepinephrine-dependent and independent mechanisms of persistent effects of amphetamine in rat cerebellumS M Sorensen, S Hattox, S W Johnson, et al.Journal of Neurophysiology|March 1, 1994
Effects of anoxia on rat midbrain dopamine neuronsN B Mercuri, A Bonci, S W Johnson, et al.Seminars in Oncology|June 20, 1998
The biology of ovarian cancerN Auersperg, M I Edelson, S C Mok, et al.Cancer Research|March 1, 1997
Increased platinum-DNA damage tolerance is associated with cisplatin resistance and cross-resistance to various chemotherapeutic agents in unrelated human ovarian cancer cell linesS W Johnson, P B Laub, J S Beesley, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 2, 2005
Dopamine receptors set the pattern of activity generated in subthalamic neuronsJ Baufreton, Z-T Zhu, M Garret, et al.Pageof 16